Ryo Shiode

Ehime University

Papers

1

Total Citations

1

H-Index

1

About

Dr. Ryo Shiode is a pioneering urologic surgeon whose work sits at the intersection of advanced robotics and immuno-oncology for renal cell carcinoma (RCC). His research focuses on refining minimally invasive surgical techniques for complex, high-risk cases, particularly RCC with inferior vena cava (IVC) tumor thrombi. Dr. Shiode’s major contribution is demonstrating the feasibility and safety of robot-assisted radical nephrectomy (RARN) with IVC thrombectomy following modern immunotherapy. His landmark 2024 case report is among the first to describe this procedure after pembrolizumab and axitinib combination therapy, a setting where surgical outcomes were previously unknown. While his work is early-stage, its significance lies in bridging the gap between neoadjuvant systemic therapy and complex robotic surgery, potentially expanding surgical candidacy for patients with advanced disease. This study has already garnered attention for addressing a critical unmet need in urologic oncology. Dr. Shiode’s research is shaping future protocols for integrating immunotherapy with robotic surgery, offering new hope for patients with challenging RCC presentations.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
A case report of robot-assisted radical nephrectomy and inferior vena cava thrombectomy in a patient with renal cell carcinoma after pembrolizumab and axitinib combination therapy
1 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Ehime University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago